Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of Australia in 2015 was 23.86 million, having grown at a CAGR of 2% from 2008. Medicare is Australia’s public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.

In 2015, the government spent $22.03 billion on R&D on medical and health science and exported $3.53 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $22.30 billion in 2015 and is projected to reach $25.20 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 2%. The medical device market was valued at $8.85 billion in 2015 and is projected to grow at a CAGR of 0.1% to $11.44 billion by 2020. These positive growth trends can be primarily attributed to -

  • An increasingly elderly population
  • Universal health coverage
  • Government initiatives
Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Alphapharm, Apotex, Aspen Pharmacare (Aspen), Pfizer and AstraZeneca; and profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Siemens Healthcare, Philips Healthcare, GSK and Alcon
  • An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Australian healthcare market
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Australia’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Australia’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Overview of Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Exports and Imports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Overview of Top Five Disease Areas
3.1.6 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of the Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share in Healthcare Spending
4.1.5 Price Trend in Healthcare Services
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Government Structural Balance
5.3.9 Government Net Debt
5.3.10 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Public and Private Sector Share
5.6.4 Spending in Pharmaceutical Research and Development
5.7 Trade Associations
5.7.1 Australian Pharmaceutical Marketing and Research Group
5.7.2 Pharmacy Guild of Australia
5.7.3 Generic Medicines Industry Association
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasts
7.3.4 Expert Panel
7.4 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical Market, Australia, Revenue ($bn), 2008-2015
Table 2: Pharmaceutical Market, Australia, Revenue ($bn), 2016-2020
Table 3: Pharmaceutical Market, Australia, Exports and Imports ($bn), 2008-2015
Table 4: Pharmaceutical Market, Australia, Pharmacy and Wholesale Mark-up (%), 2016
Table 5: Pharmaceutical Market, Australia, Biotechnology Companies, Market Capitalization, Q4 2013
Table 6: Pharmaceutical Market, Australia, Top Five Therapeutic Areas, Pharmaceutical Expenditure $bn), 2015
Table 7: Pharmaceutical Market, Australia, Major Suppliers to PBS, Market Shares (%), 2015
Table 8: Pharmaceutical Market, Alphapharm, Global, Major Products, 2016
Table 9: Pharmaceutical Market, Apotex, Global, Major Products, 2016
Table 10: Pharmaceutical Market, Apotex, Global, Late-Stage Pipeline, 2016
Table 11: Pharmaceutical Market, Aspen, Global, Major Products, 2016
Table 12: Pharmaceutical Market, Pfizer, Global, Major Products, 2015
Table 13: Pharmaceutical Market, Pfizer, Global, Planned Filings, 2015
Table 14: Pharmaceutical Market, AstraZeneca, Global, Major Products, 2016
Table 15: Pharmaceutical Market, AstraZeneca, Global, Late-Stage Pipeline, 2016
Table 16: Medical Device Market, Australia, Revenue ($bn), 2008-2015
Table 17: Medical Device Market, Australia, Revenue ($bn), 2016-2020
Table 18: Medical Device Market, Australia, Revenue by Segment, 2015
Table 19: IVD Market, Australia, Revenue ($m), 2008-2015
Table 20: IVD Market, Australia, Revenue ($m) and Market Share (%) of Major Players, 2014
Table 21: Orthopedic Device Market, Australia, Revenue ($m), 2008-2015
Table 22: Orthopedic Device Market, Australia, Revenue ($m) and Market Share (%) of Major Players, 2015
Table 23: Cardiovascular Device Market, Australia, Revenue ($m), 2008-2015
Table 24: Cardiovascular Device Market, Australia, Revenue ($m) and Market Share (%) of Major Players, 2014
Table 25: Diagnostic Imaging Market, Australia, Revenue ($m), 2008-2015
Table 26: Diagnostic Imaging Market, Australia, Revenue ($m) and Market Share (%) of Major Players, 2012
Table 27: Ophthalmic Device Market, Australia, Revenue ($m), 2008-2015
Table 28: Ophthalmic Device Market, Australia, Revenue ($m) and Market Share (%) of Major Players, 2012
Table 29: Medical Device Market, Australia, Revenue ($m) and Market Share (%) of Major Players, 2012
Table 30: GE Healthcare, Global, Major Products, 2015
Table 31: GE Healthcare, Global, Pipeline Products, 2015
Table 32: Siemens Healthcare, Global, Major Products, 2015
Table 33: Philips Healthcare, Global, Major Products, 2015
Table 34: Major Products, Alcon, Major Products, 2015
Table 35: Market Access, Australia, Private Health Insurance Rate (%), 2014
Table 36: Market Access, Australia, Private Insurance Coverage Population (million), 2008-2015
Table 37: Healthcare Spending, Australia, Out-of-Pocket Expenditure (%), 2008-2015
Table 38: Market Access, Australia, Total Health Price Index (%), 2008-2014
Table 39: Market Access, Australia, Classification of Medical Devices, 2016
Table 40: Market Access, Australia, Conformity Assessment of a Medical Device, 2016
Table 41: Market Access, Australia, Regulation of Advertising of Therapeutic Goods, Australia, 2016
Table 42: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2008-2015
Table 43: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2016-2020
Table 44: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2008-2015
Table 45: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2016-2020
Table 46: Economic Indicators, Australia, Gross National Income per Capita ($), 2008-2014
Table 47: Economic Indicators, Australia, Average Consumer Price Index, 2008-2015
Table 48: Economic Indicators, Australia, Average Consumer Price Index, 2016-2020
Table 49: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2008-2015
Table 50: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2016-2020
Table 51: Economic Indicators, Australia, Currency Exchange Rate (AUD/$), 2008-2015
Table 52: Economic Indicators, Australia, Foreign Direct Investment ($bn), 2008-2014
Table 53: Economic Indicators, Australia, Foreign Exchange Reserves ($bn), 2008-2015
Table 54: Economic Indicators, Australia, Imports of Goods and Services ($bn), 2008-2014
Table 55: Economic Indicators, Australia, Exports of Goods and Services ($bn), 2008-2014
Table 56: Economic Indicators, Australia, General Government Structural Balance ($bn), 2008-2015
Table 57: Economic Indicators, Australia, General Government Net Debt (% of GDP), 2008-2015
Table 58: Economic Indicators, Australia, General Government Net Debt (% of GDP), 2016-2020
Table 59: Economic Indicators, Australia, Major Industries, Industry Value Added ($m), 2014-2015
Table 60: Demographics, Australia, Population (million), 2008-2015
Table 61: Demographics, Australia, Population (million), 2016-2020
Table 62: Demographics, Australia, Population, Urban and Rural Population Share (%), 2008-2015
Table 63: Demographics, Australia, Population, Urban and Rural Population Share Forecast (%), 2016-2020
Table 64: Demographics, Australia, Population Distribution by Age Group (%), 2008-2015
Table 65: Demographics, Australia, Population Distribution by Age Group (%), 2016-2020
Table 66: Demographics, Australia, Births (per 1,000 population), 2008-2015
Table 67: Demographics, Australia, Mortality (per 1,000 population), 2008-2015
Table 68: Demographics, Australia, Major Causes of Mortality, 2014
Table 69: Demographics, Australia, Mortality Rate of Children under Five (per 1,000 Live Births), 2008-2015
Table 70: Demographics, Australia, Immunization Rate (%), 2008-2015
Table 71: Demographics, Australia, Major Causes of Male Mortality (%), 2014
Table 72: Demographics, Australia, Major Causes of Female Mortality (‘000), 2014
Table 73: Demographics, Australia, Gender Ratio (M/F), 2008-2015
Table 74: Demographics, Australia, Life Expectancy at Birth (years), 2008-2015
Table 75: Demographics, Australia, Student Enrollment by Level of Education (% of Gross), 2008-2015
Table 76: Demographics, Australia, Overseas Students, 2015
Table 77: Demographics, Australia, Unemployment Rate (%), 2008-2013
Table 78: Major Diseases, Australia, Disability-Adjusted Life Years (as % of Total Burden), 2011
Table 79: Healthcare Infrastructure, Australia, Public and Private Hospitals, 2008-2015
Table 80: Healthcare Infrastructure, Australia, Public Acute and Psychiatric Hospitals (per 1,000 population), 2008-2015
Table 81: Healthcare Infrastructure, Australia, Private Free-Standing Day and Other Private Hospitals (per 1,000 population), 2008-2015
Table 82: Healthcare Infrastructure, Australia, Diagnostic Equipments (per million population), 2008-2013
Table 83: Healthcare Infrastructure, Australia, Hospital Beds (per 1,000 population), 2008-2015
Table 84: Healthcare Infrastructure, Australia, Public Hospital Beds by Type of Care (per 1,000 population), 2008-2015
Table 85: Healthcare Infrastructure, Australia, Doctors (per 100,000 population), 2008-2015
Table 86: Healthcare Infrastructure, Australia, PM10 (µg/m3), 2008-2015
Table 87: Healthcare Infrastructure, Australia, CO2 Emissions (million metric tons), 2008-2015
Table 88: Healthcare Infrastructure, Australia, Nurses (per 1,000 population), 2008-2015
Table 89: Healthcare Infrastructure, Australia, Pharmacists (per 1,000 population), 2008-2015
Table 90: Healthcare Infrastructure, Australia, Dentists (per 1,000 population), 2008-2015
Table 91: Healthcare Expenditure, Australia, Healthcare Expenditure (% of GDP), 2008-2015
Table 92: Healthcare Expenditure, Australia, Share of Major Components (%), 2014
Table 93: Healthcare Expenditure, Australia, Public-Private Share ($ per capita), 2008-2015
Table 94: Healthcare Expenditure, Australia, Pharmaceutical R&D ($bn), 2008-2015
Table 95: Healthcare Expenditure, Australia, Major Healthcare Trade Fairs, 2016
1.2 List of Figures
Figure 1: Pharmaceutical Market, Australia, Revenue ($bn), 2008-2015
Figure 2: Pharmaceutical Market, Australia, Revenue ($bn), 2016-2020
Figure 3: Pharmaceutical Market, Australia, Exports and Imports ($bn), 2008-2015
Figure 4: Pharmaceutical Market, Australia, Distribution Channels, 2016
Figure 5: Pharmaceutical Market, Australia, Top Five Therapeutic Areas, Pharmaceutical Expenditure ($bn), 2015
Figure 6: Pharmaceutical Market, Australia, Major Suppliers to PBS, Market Share (%), 2015
Figure 7: Medical Device Market, Australia, Revenue ($bn), 2008-2015
Figure 8: Medical Device Market, Australia, Revenue ($bn), 2016-2020
Figure 9: Medical Device Market, Australia, Revenue by Segment ($m), 2015
Figure 10: IVD Market, Australia, Revenue ($m), 2008-2015
Figure 11: IVD Market, Australia, Market Share of Major Players (%), 2014
Figure 12: Orthopedic Device Market, Australia, Revenue ($m), 2008-2015
Figure 13: Orthopedic Device Market, Australia, Market Share of Major Players (%), 2015
Figure 14: Cardiovascular Device Market, Australia, Revenue ($m), 2008-2015
Figure 15: Cardiovascular Device Market, Australia, Market Share of Major Players (%), 2014
Figure 16: Diagnostic Imaging Market, Australia, Revenue ($m), 2008-2015
Figure 17: Diagnostic Imaging Market, Australia, Market Share of Major Players (%), 2012
Figure 18: Ophthalmic Device Market, Australia, Revenue ($m), 2008-2015
Figure 19: Ophthalmic Device Market, Australia, Market Share of Major Players (%), 2012
Figure 20: Medical Device Market, Australia, Revenue of Major Players ($m), 2012
Figure 21: Healthcare Market, Australia, Drivers and Barriers, 2016
Figure 22: Healthcare System, Australia, Therapeutic Goods Administration, 2016
Figure 23: Healthcare System, Australia, Pharmaceuticals and Devices Reimbursement Process, 2014
Figure 24: Healthcare System, Australia, Pharmaceuticals Reimbursement Process, 2014
Figure 25: Healthcare System, Australia, Medical Devices Reimbursement Process, 2014
Figure 26: Market Access, Australia, Private Insurance Coverage Population (million), 2008-2015
Figure 27: Healthcare Spending, Australia, Out-of-Pocket Expenditure (%), 2008-2015
Figure 28: Market Access, Australia, Total Health Price Index (%), 2008-2014
Figure 29: Market Access, Australia, Registration Process Regulatory Phases, 2016
Figure 30: Market Access, Australia, Class I Non-sterile and Non-measuring Device Supply Process, 2016
Figure 31: Market Access, Australia, Supply Process for Medical Device Manufactured in Australia, 2016
Figure 32: Market Access, Australia, Supply Process for Medical Device Manufactured Overseas, 2016
Figure 33: Market Access, Australia, Supply Process for Medical Device Containing Medicine or Materials of Animal, Microbial Recombinant or Human Origin, 2016
Figure 34: Market Access, Australia, Patent Approval Process, 2015
Figure 35: Market Access, Australia, Trademark Approval Process, 2015
Figure 36: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2008-2015
Figure 37: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2016-2020
Figure 38: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2008-2015
Figure 39: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2016-2020
Figure 40: Economic Indicators, Australia, Gross National Income per Capita ($), 2008-2014
Figure 41: Economic Indicators, Australia, Average Consumer Price Index, 2008-2015
Figure 42: Economic Indicators, Australia, Average Consumer Price Index, 2016-2020
Figure 43: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2008-2015
Figure 44: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2016-2020
Figure 45: Economic Indicators, Australia, Currency Exchange Rate (AUD/$), 2008-2015
Figure 46: Economic Indicators, Australia, Foreign Direct Investment ($bn), 2008-2014
Figure 47: Economic Indicators, Australia, Foreign Exchange Reserves ($bn), 2008-2015
Figure 48: Economic Indicators, Australia, Imports of Goods and Services ($bn), 2008-2014
Figure 49: Economic Indicators, Australia, Exports of Goods and Services ($bn), 2008-2014
Figure 50: Economic Indicators, Australia, General Government Structural Balance ($bn), 2008-2015
Figure 51: Economic Indicators, Australia, General Government Net Debt (% of GDP), 2008-2015
Figure 52: Economic Indicators, Australia, General Government Net Debt (% of GDP), 2016-2020
Figure 53: Economic Indicators, Australia, Major Industries, Industry Value Added ($m), 2014-2015
Figure 54: Demographics, Australia, Population (million), 2008-2015
Figure 55: Demographics, Australia, Population (million), 2016-2020
Figure 56: Demographics, Australia, Population, Urban and Rural Population Share (%), 2008-2015
Figure 57: Demographics, Australia, Population, Urban and Rural Population Share (%), 2016-2020
Figure 58: Demographics, Australia, Population Distribution by Age Group (%), 2008-2015
Figure 59: Demographics, Australia, Population Distribution by Age Group (%), 2016-2020
Figure 60: Demographics, Australia, Births (per 1,000 population), 2008-2015
Figure 61: Demographics, Australia, Mortality (per 1,000 population), 2008-2015
Figure 62: Demographics, Australia, Major Causes of Mortality (%), 2014
Figure 63: Demographics, Australia, Mortality Rate of Children under Five (per 1,000 live births), 2008-2015
Figure 64: Demographics, Australia, Immunization Rate (%), 2008-2015
Figure 65: Demographics, Australia, Major Causes of Male Mortality (%), 2014
Figure 66: Demographics, Australia, Major Causes of Female Mortality (%), 2014
Figure 67: Demographics, Australia, Gender Ratio (M/F), 2008-2015
Figure 68: Demographics, Australia, Life Expectancy at Birth (years), 2008-2015
Figure 69: Demographics, Australia, Student Enrollment by Level of Education (% of Gross), 2008-2015
Figure 70: Demographics, Australia, Overseas Student (%), 2015
Figure 71: Demographics, Australia, Unemployment Rate (%), 2008-2015
Figure 72: Major Diseases, Australia, Disability-Adjusted Life Years (as % of Total Burden), 2011
Figure 73: Healthcare Infrastructure, Australia, Public and Private Hospitals, 2008-2015
Figure 74: Healthcare Infrastructure, Australia, Public Acute and Psychiatric Hospitals (per 1,000 population), 2008-2015
Figure 75: Healthcare Infrastructure, Australia, Private Free-Standing Day and Other Private Hospitals (per 1,000 population), 2008-2015
Figure 76: Healthcare Infrastructure, Australia, Diagnostic Equipments (per million population), 2008-2015
Figure 77: Healthcare Infrastructure, Australia, Hospital Beds (per 1,000 population), 2008-2015
Figure 78: Healthcare Infrastructure, Australia, Hospital Beds by Type of Care (per 1,000 population), 2008-2015
Figure 79: Healthcare Infrastructure, Australia, Doctors (per 1,000 population), 2008-2015
Figure 80: Healthcare Infrastructure, Australia, PM2.5 (µg/m3), 2008-2015
Figure 81: Healthcare Infrastructure, Australia, CO2 Emissions (million metric tons), 2008-2015
Figure 82: Healthcare Infrastructure, Australia, Nurses (per 1,000 population), 2008-2015
Figure 83: Healthcare Infrastructure, Australia, Pharmacists (per 1,000 population), 2008-2015
Figure 84: Healthcare Infrastructure, Australia, Dentists (per 1,000 population), 2008-2015
Figure 85: Healthcare Expenditure, Australia, Healthcare Expenditure (% of GDP), 2008-2015
Figure 86: Healthcare Expenditure, Australia, Major Components (%), 2014
Figure 87: Healthcare Expenditure, Australia, Public-Private Share ($ per capita), 2008-2015
Figure 88: Healthcare Expenditure, Australia, Pharmaceutical R&D ($bn), 2008-2015
Figure 89: Healthcare Market, Australia, Opportunities and Challenges, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report